Triazole Antifungals: Mechanism, Uses & Side Effects

What Are Triazole Antifungals?

Triazole antifungals are a class of antifungal medications belonging to the broader group of azole antifungals. They are characterized by a triazole ring in their chemical structure. Triazoles are used to treat both superficial and systemic (whole-body) fungal infections and are among the most widely prescribed antifungals in modern clinical medicine.

Mechanism of Action

Triazole antifungals work by selectively inhibiting the fungal enzyme lanosterol 14-alpha-demethylase, which is part of the fungal cytochrome P450 system (CYP51). This enzyme plays a critical role in the biosynthesis of ergosterol, the primary structural component of the fungal cell membrane.

• Inhibition of the enzyme blocks ergosterol production.
• Toxic intermediate compounds such as lanosterol accumulate within the fungal cell.
• The fungal cell membrane becomes destabilized, either inhibiting fungal growth (fungistatic effect) or killing the fungus (fungicidal effect, depending on the agent and concentration).

Because human cells do not require ergosterol, this target is fungus-specific, which explains the selective toxicity of this drug class.

Key Active Substances

Triazole antifungals are divided into first-generation and second-generation agents:

First-Generation Triazoles

• Fluconazole: Widely used, well tolerated, commonly prescribed for Candida infections and cryptococcal meningitis.
• Itraconazole: Broader spectrum than fluconazole, effective against molds; used for Aspergillus and dermatophyte infections.

Second-Generation Triazoles

• Voriconazole: Extended spectrum; drug of choice for invasive aspergillosis.
• Posaconazole: Broad spectrum including Mucor species; used for prophylaxis and treatment in immunocompromised patients.
• Isavuconazole: Newer agent with good activity against Aspergillus and Mucorales, favorable tolerability profile.

Indications

Triazole antifungals are used to treat a wide range of fungal infections:

• Candidiasis: Infections caused by Candida species (e.g., oropharyngeal candidiasis, vaginal yeast infections, invasive candidemia)
• Aspergillosis: Infections caused by Aspergillus species, especially in immunosuppressed patients
• Cryptococcosis: Including cryptococcal meningitis in HIV-positive patients
• Dermatophytosis: Fungal infections of the skin, hair, and nails
• Prophylaxis: Prevention of fungal infections in high-risk patients (e.g., after stem cell transplantation)

Dosage and Administration

Dosage depends on the specific agent, the type and severity of the infection, and the condition of the patient. Triazoles are available in several formulations:

• Oral administration (tablets, capsules, solution)
• Intravenous infusion for severe systemic infections
• Topical application (creams, solutions) for superficial skin fungal infections

Duration of treatment varies widely depending on the indication, ranging from a few days (e.g., uncomplicated vaginal candidiasis) to several months (e.g., invasive aspergillosis).

Side Effects

Triazole antifungals are generally well tolerated, but may cause the following side effects:

• Gastrointestinal: Nausea, vomiting, abdominal pain, diarrhea
• Hepatotoxicity: Elevated liver enzymes; rarely, severe liver damage (regular monitoring is recommended)
• Skin reactions: Rash; rarely, severe reactions such as Stevens-Johnson syndrome
• Visual disturbances: Particularly with voriconazole; transient changes in vision
• QT prolongation: Prolongation of the QT interval on ECG; caution in patients with cardiac arrhythmias
• Drug interactions: Pronounced due to inhibition of the cytochrome P450 system; numerous clinically relevant interactions possible

Resistance

The growing resistance of fungal pathogens -- particularly Candida auris and certain Aspergillus strains -- to triazoles represents an increasing clinical challenge. Resistance can arise through mutations in the CYP51 gene, overexpression of efflux pumps, or other mechanisms. Careful and targeted use of triazoles is therefore essential to minimize the development of resistance.

Contraindications and Precautions

• Known hypersensitivity to the active ingredient or other azoles
• Concomitant use of drugs with a narrow therapeutic index metabolized by CYP450 (e.g., certain statins, anticoagulants)
• Pregnancy: Some triazoles (especially high-dose fluconazole) may be teratogenic and should be avoided
• Severe hepatic impairment requires special caution

References

1. Pappas PG, Kauffman CA, Andes DR et al. - Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases. 2016;62(4):e1-e50.
2. Patterson TF, Thompson GR, Denning DW et al. - Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases. 2016;63(4):e1-e60.
3. Brunton LL, Hilal-Dandan R, Knollmann BC (eds.) - Goodman and Gilman's The Pharmacological Basis of Therapeutics. 13th edition. McGraw-Hill Education, New York 2018.